{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:59:13Z","timestamp":1782219553328,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.autrev.2021.102824","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T23:40:56Z","timestamp":1618962056000},"page":"102824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?"],"prefix":"10.1016","volume":"20","author":[{"given":"Philippe","family":"Mertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Jeannel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Guffroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Lescuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"Korganow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Rondeau-Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Christophe","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7(1)","key":"10.1016\/j.autrev.2021.102824_bb0005","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"13","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"issue":"5","key":"10.1016\/j.autrev.2021.102824_bb0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12026-020-09152-6","article-title":"Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine","volume":"68","author":"Kanduc","year":"2020","journal-title":"Immunol Res"},{"issue":"395(10229)","key":"10.1016\/j.autrev.2021.102824_bb0015","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"28","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102824_bb0020","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm, what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front Immunol"},{"issue":"368(6490)","key":"10.1016\/j.autrev.2021.102824_bb0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"01","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.102824_bb0030","article-title":"Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2","volume":"30","author":"Hallaj","year":"2020","journal-title":"Immunol Cell Biol"},{"issue":"6504","key":"10.1016\/j.autrev.2021.102824_bb0035","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.autrev.2021.102824_bb0040","doi-asserted-by":"crossref","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2021.102824_bb0045","doi-asserted-by":"crossref","first-page":"102538","DOI":"10.1016\/j.autrev.2020.102538","article-title":"Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning","volume":"19","author":"Shoenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102824_bb0050","doi-asserted-by":"crossref","first-page":"108426","DOI":"10.1016\/j.clim.2020.108426","article-title":"On the molecular determinants of the SARS-CoV-2 attack","volume":"215","author":"Kanduc","year":"2020","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2021.102824_bb0055","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1167\/iovs.08-2649","article-title":"Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan","volume":"50","author":"Okunuki","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.autrev.2021.102824_bb0060","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.2353\/ajpath.2007.061205","article-title":"Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma","volume":"170","author":"Shen","year":"2007","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.autrev.2021.102824_bb0065","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","article-title":"The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/mas receptor Axis: evidence from basic and clinical research","volume":"18","author":"Rodrigues Prestes","year":"2017","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.autrev.2021.102824_bb0070","article-title":"Functional alteration of innate T cells in critically ill Covid-19 patients","volume":"6","author":"Jouan","year":"2020","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.autrev.2021.102824_bb0075","doi-asserted-by":"crossref","first-page":"13181","DOI":"10.1038\/s41598-019-49903-6","article-title":"Activation of mucosal-associated invariant T cells in the lungs of sarcoidosis patients","volume":"9","author":"Matsuyama","year":"2019","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.autrev.2021.102824_bb0080","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/cid\/ciaa247","article-title":"A comparative study on the clinical features of coronavirus 2019 (COVID-19) pneumonia with other pneumonias","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.autrev.2021.102824_bb0085","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00109-006-0094-9","article-title":"Lessons from SARS: control of acute lung failure by the SARS receptor ACE2","volume":"84","author":"Kuba","year":"2006","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.autrev.2021.102824_bb0090","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1038\/ncomms4595","article-title":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients","volume":"5","author":"Huang","year":"2014","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.autrev.2021.102824_bb0095","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1172\/JCI61368","article-title":"Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis","volume":"124","author":"Zhang","year":"2014","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.autrev.2021.102824_bb0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/labinvest.2008.42","article-title":"Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells","volume":"88","author":"Kato","year":"2008","journal-title":"Lab Investig"},{"issue":"5","key":"10.1016\/j.autrev.2021.102824_bb0105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2018.15","article-title":"Angiotensin-converting enzyme in innate and adaptive immunity","volume":"14","author":"Bernstein","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.autrev.2021.102824_bb0110","first-page":"R208","article-title":"Regulation of T-cell function by endogenously produced angiotensin II","volume":"296","author":"Hoch","year":"2009","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"10","key":"10.1016\/j.autrev.2021.102824_bb0115","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/prca.200600906","article-title":"Screening of serum samples from Wegener\u2019s granulomatosis patients using antibody microarrays","volume":"1","author":"Olle","year":"2007","journal-title":"Proteomics Clin Appl"},{"issue":"4","key":"10.1016\/j.autrev.2021.102824_bb0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2016.10.002","article-title":"Macrophages\u2019 Choice: Take It In or Keep It Out","volume":"45","author":"Nathan","year":"2016","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.autrev.2021.102824_bb0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrrheum.2011.93","article-title":"Sarcoidosis--scientific progress and clinical challenges","volume":"7","author":"Chen","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2021.102824_bb0130","first-page":"271","article-title":"Propionibacterium acnes isolated from lymph nodes of patients with sarcoidosis","volume":"32","author":"de Brouwer","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.autrev.2021.102824_bb0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccm.2015.08.001","article-title":"The etiologic role of infectious antigens in Sarcoidosis pathogenesis","volume":"36","author":"Celada","year":"2015","journal-title":"Clin Chest Med"},{"issue":"4","key":"10.1016\/j.autrev.2021.102824_bb0140","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1172\/JCI110142","article-title":"Effect of SQ 14225, an inhibitor of angiotensin I-converting enzyme, on the granulomatous response to Schistosoma mansoni eggs in mice","volume":"67","author":"Weinstock","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.102824_bb0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2017.01.020","article-title":"The role of pattern recognition receptors in lung sarcoidosis","volume":"808","author":"Mortaz","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"6928","key":"10.1016\/j.autrev.2021.102824_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature01433","article-title":"Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1","volume":"422","author":"Treiner","year":"2003","journal-title":"Nature."},{"issue":"3","key":"10.1016\/j.autrev.2021.102824_bb0155","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.4049\/jimmunol.176.3.1618","article-title":"MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response","volume":"176","author":"Kawachi","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2021.102824_bb0160","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/imcb.1034","article-title":"MAIT cells: an historical and evolutionary perspective","volume":"96","author":"Lantz","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2021.102824_bb0165","first-page":"5(51)","article-title":"MAIT cell activation and dynamics associated with COVID-19 disease severity","volume":"28","author":"Parrot","year":"2020","journal-title":"Sci Immunol"},{"issue":"49","key":"10.1016\/j.autrev.2021.102824_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"5","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:21:41Z","timestamp":1761600101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221000963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1568997221000963"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102824","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102824"}}